RAGNO, Pia
 Distribuzione geografica
Continente #
NA - Nord America 3.899
EU - Europa 875
AS - Asia 361
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.137
Nazione #
US - Stati Uniti d'America 3.881
UA - Ucraina 302
CN - Cina 235
IT - Italia 214
DE - Germania 110
IE - Irlanda 92
TR - Turchia 71
FI - Finlandia 63
SE - Svezia 57
VN - Vietnam 30
CA - Canada 18
RU - Federazione Russa 17
IN - India 8
GB - Regno Unito 6
HK - Hong Kong 4
PH - Filippine 4
DK - Danimarca 3
PK - Pakistan 3
FR - Francia 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
HU - Ungheria 1
KR - Corea 1
LU - Lussemburgo 1
MY - Malesia 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
TW - Taiwan 1
Totale 5.137
Città #
Ann Arbor 1.154
Houston 500
Woodbridge 394
Jacksonville 375
Chandler 368
Princeton 266
Wilmington 167
Dublin 91
Ashburn 79
Salerno 75
Izmir 71
Andover 64
Nanjing 59
Boardman 58
Pellezzano 45
Shenyang 35
Dong Ket 30
Beijing 25
Jiaxing 23
Fairfield 22
Norwalk 21
Hebei 17
Düsseldorf 16
Ottawa 16
Tianjin 16
Changsha 15
Nanchang 15
Redwood City 11
Falls Church 9
Jinan 9
Nürnberg 9
Dearborn 8
Pune 8
San Diego 8
Washington 7
New York 6
Seattle 6
Zhengzhou 6
Eboli 5
Napoli 5
Oliveto Citra 5
Bracigliano 4
Hong Kong 4
Los Angeles 4
Marano Di Napoli 4
Cambridge 3
Copenhagen 3
Guangzhou 3
Menlo Park 3
Mestre 3
Milan 3
Shanghai 3
Tappahannock 3
Ariano Irpino 2
Caserta 2
Hefei 2
Marano di Napoli 2
Medicina 2
Naples 2
Nola 2
Portici 2
Tokyo 2
Altavilla Silentina 1
Amsterdam 1
Angri 1
Arzano 1
Bad Homburg 1
Baotou 1
Boston 1
Brno 1
Brooklyn 1
Budapest 1
Corydon 1
Dubai 1
Dugenta 1
Edinburgh 1
Esslingen am Neckar 1
Faisalabad 1
Indiana 1
Lahore 1
Lanzhou 1
Lappeenranta 1
Leipzig 1
London 1
Luxembourg 1
Montecorvino Rovella 1
Multan 1
Munich 1
Ningbo 1
Pantai 1
Phoenix 1
Rome 1
Ronciglione 1
San Francisco 1
San Jose 1
Sant'Antimo 1
Secaucus 1
Serra 1
Siano 1
Southend 1
Totale 4.215
Nome #
The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface 121
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 111
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 108
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 101
Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. 99
The urokinase-receptor in infectious diseases. 98
Expression and function of the uPA-uPAR system and the FMLP receptor family in human basophils 96
Discovery of new small molecules targeting the vitronectin binding site of the urokinase receptor that block cancer cell invasion. 95
Discovery of New Inhibitors of Cdc25B Dual Specificity Phosphatases by Structure-Based Virtual Screening. 92
67 kDa laminin receptor: structure, function and role in cancer and infection. 92
uPAR REGULATES PERICELLULAR PROTEOLYSIS THROUGH A MECHANISM INVOLVING INTEGRINS AND fMLF-RECEPTORS 92
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 92
PED/PEA-15 interacts with the 67 kDa laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis. 91
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 89
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 89
Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR. 87
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 86
Upregulation of the N-formyl peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts 85
Role of the urokinase receptor in hematopoietic stem cell transplantation 84
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 83
The metastasis-associated 67kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 83
Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. 82
Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma. 81
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 81
The plasminogen activator system in fibroblasts from systemic sclerosis. 80
Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells 78
Role of the Urokinase Receptor (uPAR) in the Cross-Talk of Hematopoietic Stem Cells with the Bone Marrow Microenvironment 78
Involvement of the 67 kDa laminin receptor in haematopoietic stem cell mobilisation and homing 78
Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells. 78
Structure and Functions of the Urokinase Receptor 77
The metastasis-associated 67 kDa laminin receptor is involved in G-CSF-induced haematopoietic stem cell mobilisation 77
Upar soluble forms and hematopoietic stem cell transplantion 77
Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells 77
Urokinase-type plasminogen-activator receptor in human thyroid cells. 76
Hp(2-20) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors. 76
Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence. 76
A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation. 74
Production of urokinase-type plasminogen activator by normal and transformed rat thyroid cells in culture. 74
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor 73
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism. 72
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 71
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. 70
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 69
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells 69
The cleavage of the urokinase receptor regulates its multiple functions. 68
The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. 68
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? 67
RhoB regulates uPAR signalling 66
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. 66
uPAR and Proteases in Mobilizationof Hematopoietic Stem Cells 65
The urokinase receptor takes control of cell migration through a mechanism involving integrins and fMLF receptors. 65
The urokinase receptor associates to fMLF chemotaxis receptors 65
In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. 64
Role of the urokinase-type plasminogen activator receptor in haematopoietic stem cell mobilisation 64
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor 63
Involvement of the urokinase receptor in the cross-talk between hematopoietic stem/progenitor cells and the bone marrow microenvironment. 63
Urokinase-type plasminogen-activator and normal thyroid cell adhesion to the extracellular matrix 62
Discovery of new small molecules targeting the vitronectin binding site of the urokinase receptor that block normal and leukemic cell migration 62
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors 60
PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer 59
miRNA-MEDIATED CO-REGULATION OF UROKINASE RECEPTOR AND CXCR4 EXPRESSION 58
Role of uPA/uPAR in the Modulation of Angiogenesis 58
Post-transcriptional regulation of gene expression in the plasminogen activation system. 57
Expression and function of the UPA dependent plasminogen activation system in scleroderma 53
Recent advances in the function of the 67 kDa laminin receptor and its targeting for personalized therapy in cancer 50
null 41
Scleroderma and plasminogen activation system: Expression and function of the urokinase-mediated plasminogen activation system in fibroblasts from systemic sclerosis | 35
N-formyl peptide receptors induce radical oxygen production in fibroblasts derived from systemic sclerosis by interacting with a cleaved form of urokinase receptor 34
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 34
TLR4 Response to LPS Is Reinforced by Urokinase Receptor 24
The urokinase receptor: A multifunctional receptor in cancer cell biology. therapeutic implications 22
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 17
Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer 8
Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children 3
A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs. 1
Totale 5.240
Categoria #
all - tutte 12.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019111 0 0 0 0 0 0 0 0 0 18 90 3
2019/2020591 163 0 69 22 57 7 66 3 66 42 83 13
2020/2021485 16 61 66 2 74 19 63 0 69 2 72 41
2021/2022483 1 0 0 3 27 12 8 18 69 71 57 217
2022/2023784 74 67 7 114 123 159 1 67 127 1 28 16
2023/2024221 31 63 18 7 14 45 9 22 2 10 0 0
Totale 5.240